Cedric the Entertainer & SUTC Promote Research Awareness to Minority Populations Disproportionately Impacted by Cancer

Cedric the Entertainer & SUTC Promote Research Awareness to Minority Populations Disproportionately Impacted by Cancer

Stand Up to Cancer (SU2C), a non-profit organization out of Hollywood entertainment world that supports cancer research, recently teamed with Cedric the Entertainer to bring more awareness of cancer research to People of Color, including African Americans. The star of CBS’ The Neighborhood will star in a public service announcement seeking to educate and encourage cancer patients to learn more about research.

This public service announcement (PSA) is the third in a series of PSAs supporting Stand Up to Cancer’s Health Equity Initiative reported on by the TrialSite. The goal: have the same opportunity to access advanced therapies that can extend or even save a life.

This new PSA follows campaigns by actors Sonequa Martin-Green. Now with Cedric the Entertainer, SU2C hopes to connect with a large following as Cedric the Entertainer counts as his credits CBS’ The Neighborhood, Cedric the Entertainer Presents and The Last O.G. Cedric the Entertainer has been a supporter of SU2C since 2018 as his mother’s battle with uterine cancer activated him to join the cause.

Its Personal

Cedric the Entertainer shared with the world, “My mother’s cancer journey taught me about the value of advocating for yourself and knowing your options.” He conveyed, “Participation in cancer clinical trials is extremely low in the Black community, and I am proud to work with Stand Up To Cancer and take action to address this important issue.”

SUTC CEO Sung Poblete, PhD, RN shared her gratitude, noting the organization was “honored Cedric the Entertainer has joined us to raise awareness about the importance and benefits of cancer clinical trials.”

SUTC Health Equity Initiative

The SU2C Health Equity Initiative seeks to diversify participation in clinical trials in a bid to ensure patients of all racial and ethnic backgrounds benefit equally from the potential of cancer treatments and that research addresses differences in genetics, metabolism and physiology. Currently, data from the FDA shows only 4 percent of total cancer clinical trial participants are Black, and 5 percent are Hispanic, despite the fact that people of color have the highest mortality rates and shortest overall survival rates for most cancers.

Call to Action: Visit SUTC to learn more about how to participate in clinical trials in this link. COVID-19 has shaken up cancer research. The virus makes cancer patients even more vulnerable. For those interested in learning more about how cancer patients, particularly those contending with cancers of the lung or blood, and those whose treatment suppresses the immune system, visit the following link for COVID-19 resources